JH-VIII-49
JH-VIII-49 (compound 10) is a potent and selective CDK8 inhibitor (IC50=16 nM) with excellent biological activity. JH-VIII-49 promotes CDK8 inhibition through its steroid backbone design. JH-VIII-49 can be used in the synthesis of PROTAC as a target protein ligand of JH-XI-10-02 (HY-111518) [1][2].
Product Specifications
CAS Number
[2209084-73-9]
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
CDK; Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jh-viii-49.html
Smiles
C[C@@]12[C@](CC[C@@H]2C3=CC4=C(C=CN=C4)C=C3)([H])[C@@]5([H])[C@]([C@@]6(C(C[C@H](CC6)N(C)C)=CC5)C)([H])CC1
Molecular Formula
C30H40N2
Molecular Weight
428.65
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
[1]Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK8
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Mouse Monoclonal Mycobacterium avium subsp. paratuberculosis Antibody (6G11)
